Active ingredientBuserelinCat. No. P-B144-001CAS 57982-77-1Family · Pharmaceutical analytical standards
Buserelin
A synthetic analogue of the hypothalamic hormone GnRH, patented in 1974 and in clinical use since the mid-1980s for prostate cancer and endometriosis, in assisted reproduction and also in veterinary medicine. This family brings together the active ingredient, pharmacopoeial impurities, labelled standards and other impurities.
Did you know?It is one of only two GnRH analogues used in medicine that can also be given as a nasal spray; the other is nafarelin.
Go to the active ingredient →Active ingredientBuserelinCat. No. P-B144-001CAS 57982-77-1
Active ingredientBuserelin AcetateCat. No. P-B144-002CAS 68630-75-1
Pharmacopoeial impurityBuserelin EP Impurity A DitrifluoroacetateCat. No. P-B144-003
Pharmacopoeial impurityBuserelin EP Impurity B DitrifluoroacetateCat. No. P-B144-004
Pharmacopoeial impurityBuserelin EP Impurity D DitrifluoroacetateCat. No. P-B144-006
Pharmacopoeial impurityBuserelin EP Impurity E DitrifluoroacetateCat. No. P-B144-007
Isotopically labelledBuserelin-d5Cat. No. P-B144-010
ImpurityD-His-BuserelinCat. No. P-B144-012CAS 1872434-99-5No product matches your search.
EDQM standards 4
The official European Pharmacopoeia standards for this family.
Reference substanceBuserelin CRSEDQM code B1168000Family BuserelinReference substanceBuserelin for NMR identification CRSEDQM code Y0001814Family BuserelinReference substanceD-His-Buserelin CRSEDQM code B1168020Family BuserelinNeed a molecule you cannot find?
Custom synthesis of impurities, metabolites and labelled compounds, with the same characterisation level.